Teva Branded Pharmaceutical Products R&D Inc. et al v. Perrigo Pharmaceuticals Co. et al
| Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC, Norton (Waterford) Limited and Norton Healthcare Limited |
| Perrigo Pharmaceuticals Co., Perrigo Company and Catalent Pharma Solutions LLC |
| 1:2012cv01101 |
| September 5, 2012 |
| US District Court for the District of Delaware |
| Wilmington Office |
| XX US, Outside State |
| Gregory M Sleet |
| Patent |
| 35 U.S.C. § 271 Patent Infringement |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 20, 2014. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 180 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (mdb) |
Filing 179
SO ORDERED - re #178 Stipulation of Dismissal filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Respiratory LLC, Teva Branded Pharmaceutical Products R&D Inc. ***Civil Case Terminated. Signed by Chief Judge Gregory M. Sleet on 6/20/2014. (mdb)
|
| Filing 178 STIPULATION of Dismissal Without Prejudice by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (Shaw, John) |
|
ORAL ORDER CANCELLING BENCH TRIAL: The 6-day Bench Trial scheduled to begin on Wednesday, June 25, 2014, in Courtroom 4A before the Honorable Gregory M. Sleet has been CANCELLED. Ordered by Chief Judge Gregory M. Sleet on 6/20/2014. (asw)
|
| Filing 177 Official Transcript of Pretrial Conference held on 06 18 14 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/10/2014. Redacted Transcript Deadline set for 7/21/2014. Release of Transcript Restriction set for 9/17/2014. (kjm) |
| Filing 176 REDACTED VERSION of #174 Proposed Pretrial Order, by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (Attachments: #1 Part 2 of 5, #2 Part 3 of 5, #3 Part 4 of 5, #4 Part 5 of 5)(O'Byrne, Stephanie) |
| Minute Entry for proceedings held before Chief Judge Gregory M. Sleet - Final Pretrial Conference held on 6/18/2014. Discussion on the topics included in the pretrial order. (Court Reporter Kevin Maurer.) (mdb) |
|
Filing 175
ORDER - granting #61 Motion to Supplement Counterclaims in the Lead Action. Signed by Chief Judge Gregory M. Sleet on 6/13/2014. (mdb)
|
|
ORAL ORDER CHANGING THE TIME OF THE TELEPHONIC PRETRIAL CONFERENCE: The TIME of the Telephonic Pretrial Conference currently set for 4:30 PM on Wednesday, June 18, 2014, with the Honorable Gregory M. Sleet HAS BEEN CHANGED to 2:00 PM. Ordered by Chief Judge Sleet on 6/13/2014. (ctd)
|
| Filing 174 [SEALED] Proposed Pretrial Order by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (Attachments: #1 (Part 2 of 4), #2 (Part 3 of 4), #3 (Part 4 of 4))(O'Byrne, Stephanie) |
|
Filing 173
SO ORDERED - re #172 Stipulation Regarding Noninfringement filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Respiratory LLC, Teva Branded Pharmaceutical Products R&D Inc. Signed by Chief Judge Gregory M. Sleet on 6/2/2014. (mdb)
|
| Filing 172 STIPULATION (and Proposed Judgment) Regarding Noninfringement of U.S. Patent No. 8,132,712 Under The Court's Construction of the Pawl Claim Term by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (O'Byrne, Stephanie) |
| Pro Hac Vice Attorney Jeffrey A Marx for Perrigo Pharmaceuticals Co. added for electronic noticing. (dmp, ) |
| Filing 171 NOTICE OF SERVICE of Defendants' Notice Pursuant to 35 U.S.C. 282 filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
|
SO ORDERED - re #170 MOTION for Pro Hac Vice Appearance of Attorney Jeffrey A. Marx filed by Perrigo Company, Catalent Pharma Solutions LLC, Perrigo Pharmaceuticals Co. Ordered by Chief Judge Gregory M. Sleet on 5/23/2014. (mdb)
|
| Filing 170 MOTION for Pro Hac Vice Appearance of Attorney Jeffrey A. Marx - filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co.. (Attachments: #1 Marx Pro Hac Certification)(Haney, Megan) |
| Filing 169 NOTICE to Take Deposition of Richard N. Dalby, Ph.D. on May 21, 2014 at 9:00 A.M. filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(Fry, David) |
| Filing 168 NOTICE to Take Deposition of Paul Myrdal on May, 21 2014 filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
| Filing 167 NOTICE OF SERVICE of Supplemental Expert Report of Richard N. Dalby, Ph.D. filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
| Filing 166 NOTICE OF SERVICE of Supplemental Expert Report of Anthony Palmieri III, Ph.D. filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
| Filing 165 NOTICE OF SERVICE of Supplemental Expert Report of David Howlett filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
|
Filing 164
ORDER - CONSTRUING THE TERMS OF U.S. PATENT NOS. 7,105,152, 7,566,445, and 8,132,712. Signed by Chief Judge Gregory M. Sleet on 5/12/2014. (mdb)
|
| Filing 163 NOTICE OF SERVICE of DEFENDANTS FOURTH SUPPLEMENTAL INVALIDITY CONTENTIONS REGARDING U.S. PATENT NOS. 7,105,152 AND 7,566,445 filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Phillips, John) |
| Filing 162 NOTICE to Take Deposition of David Howlett on May 12, 2014 at 9:00 a.m. filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(O'Byrne, Stephanie) |
| Filing 161 MOTION for Pro Hac Vice Appearance of Attorney Deanne M. Mazzochi and Thomas R. Burns - filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co.. (Attachments: #1 Mazzochi Pro Hac Certification, #2 Burns Pro Hac Certification)(Haney, Megan) |
|
SO ORDERED - re #161 MOTION for Pro Hac Vice Appearance of Attorney Deanne M. Mazzochi and Thomas R. Burns filed by Perrigo Company, Catalent Pharma Solutions LLC, Perrigo Pharmaceuticals Co. Ordered by Chief Judge Gregory M. Sleet on 5/8/2014. (mdb)
|
| Pro Hac Vice Attorney Thomas R. Burns,Deanne M. Mazzochi for Perrigo Pharmaceuticals Co. added for electronic noticing. (dmp, ) |
| Filing 160 NOTICE to Take Deposition of Hugh Smyth on 5/14/14 and Guirag Poochikian on 5/16/14 filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
| Filing 159 NOTICE OF SERVICE of Supplemental Expert Report of Neil Elliot Spingarn, Ph.D. filed by Catalent Pharma Solutions LLC, Perrigo Company.(Phillips, John) |
| Filing 158 NOTICE OF SERVICE of 1) Expert Report of Paul Myrdal, Ph.D., 2) Expert Report of Guirag Poochikian, Ph.D., and 3) Expert Report of Hugh Smyth, Ph.D. filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(Keller, Karen) |
| Filing 157 NOTICE OF SERVICE of Defendants Third Supplemental Preliminary Invalidity Contentions Regarding U.S. Patent Nos. 7,105,152 and 7,556,445 filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Phillips, John) |
| Pro Hac Vice Attorney Natasha E. Daughtrey for Teva Branded Pharmaceutical Products R&D Inc. added for electronic noticing. (dmp, ) |
|
SO ORDERED - re #156 MOTION for Pro Hac Vice Appearance of Attorney Natasha E. Daughtrey filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Respiratory LLC, Teva Branded Pharmaceutical Products R&D Inc.. Ordered by Chief Judge Gregory M. Sleet on 4/21/2014. (mdb)
|
| Filing 156 MOTION for Pro Hac Vice Appearance of Attorney Natasha E. Daughtrey - filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (O'Byrne, Stephanie) |
| Filing 155 NOTICE OF SERVICE of Defendants' Responses and Objections to Plaintiffs' Notice of Deposition of David Wilcox filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
| Filing 154 NOTICE to Take Deposition of DAVID WILCOX on April 17, 2014 filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(Fry, David) |
|
Filing 153
SO ORDERED, re #149 Stipulation filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Respiratory LLC, Teva Branded Pharmaceutical Products R&D Inc., ORDER, Resetting Deadlines/Hearings (Completion of Expert Discovery due by 5/21/2014., Proposed Pretrial Order due by 6/11/2014., A Pretrial Conference (by telephone) is set for 6/18/2014 at 04:30 PM before Judge Gregory M. Sleet.). Ordered by Chief Judge Gregory M. Sleet on 4/14/2014. (asw)
|
| Filing 152 NOTICE OF SERVICE of (1) Perrigos Responses and Objections to Plaintiffs Notice of Rule 30(b)(6) Deposition; (2) Perrigos Responses and Objections to Plaintiffs Request for Entry Upon Land for Inspection and Other Purposes; (3) Catalents Responses and Objections to Plaintiffs Third Set of Requests for the Production of Documents and Things (Nos. 121-129); (4) Perrigos Responses and Objections to Plaintiffs Third Set of Requests for the Production of Documents and Things (Nos. 125-133); (5) Catalents Responses and Objections to Plaintiffs Notice of Rule 30(b)(6) Deposition; and, (6) Catalents Responses and Objections to Plaintiffs Request for Entry Upon Land for Inspection and Other Purposes filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Phillips, John) |
| Filing 151 Official Transcript of Telephone Conference held on 3/24/14 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 4/21/2014. Redacted Transcript Deadline set for 5/1/2014. Release of Transcript Restriction set for 6/30/2014. (kjm) |
| Filing 150 NOTICE OF SERVICE of (1) Plaintiffs' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) to Catalent Pharma Solutions, LLC (2) Plaintiffs' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) to Perrigo Pharmaceuticals Co. and Perrigo Co.(3) Plaintiffs' Third Set of Requests for the Production of Documents and Things to Catalent Pharma Solutions, LLC (Nos. 121-129) (4) Plaintiffs' Third Set of Requests for the Production of Documents and Things to Perrigo Pharmaceuticals Co. and Perrigo Co. (Nos. 125-133) (5) Plaintiffs' Request for Entry Upon Land for Inspection and Other Purposes (Catalent) (6) Plaintiffs' Request for Entry Upon Land for Inspection and Other Purposes (Perrigo) filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(Fry, David) |
| Filing 149 STIPULATION [STIPULATION AND [PROPOSED] ORDER AMENDING SCHEDULING ORDER] by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (Shaw, John) |
| Pro Hac Vice Attorney Paul F. Ware for Teva Branded Pharmaceutical Products R&D Inc. added for electronic noticing. (dmp, ) |
| Filing 148 Joint Letter to The Honorable Chief Judge Gregory M. Sleet from John W. Shaw regarding remaining terms for construction - re Telephone Conference,. (Shaw, John) |
| Filing 147 NOTICE OF SERVICE of (1) Expert Report of Joel Hay, Ph.D.; (2) Expert Report of Raoul Wolf, M.D.; (3) Rebuttal Expert Report of David Howlett Regarding Secondary Considerations (U.S. Patent Nos. 7,105,152 and 7,566,445); (4) Rebuttal Expert Report of Richard N. Dalby, Ph.D.; (5) Expert Report of Scott Megaffin; (6) Rebuttal Expert Report of Warren Finlay, Ph.D.; (7) Rebuttal Expert Report of Anthony Palmieri III, Ph.D.; (8) Rebuttal Expert Report of Neil Elliott Springarn, Ph.D.; (9) Second Expert Report of Paul Wright, Ph.D.; and (10) Third Expert Report of Ian L. Scott, D. Phil. filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
| Minute Entry for proceedings held before Judge Gregory M. Sleet - Telephone Conference Re: Discovery held on 3/24/2014. Discussion on the disputed items as listed in the Joint Agenda submission. The parties shall follow the court's directives as discussed. Proposed Amended Scheduling Order due by 5:00 PM on 3/28/2014. (Court Reporter: Kevin Maurer.) (asw) |
|
ORAL ORDER CHANGING THE TIME REGARDING DISCOVERY TELECONFERENCE (#3): The time for the Discovery Teleconference set for Monday, March 24, 2014, at 10:00 AM with the Honorable Gregory M. Sleet has been CHANGED to 10:30 AM. Counsel for plaintiff(s) is directed to arrange the conference call and contact chambers at (302) 573-4559 once all parties are on the line.. Ordered by Chief Judge Gregory M. Sleet on 3/24/2014. (asw)
|
| Filing 146 Letter to The Honorable Chief Judge Gregory M. Sleet from John W. Shaw regarding Items to be Presented at the Discovery Conference on March 24, 2014. (Shaw, John) |
| Filing 145 NOTICE to Take Deposition of Stephen G. Kunin on March 19, 2014 filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(Fry, David) |
|
ORAL ORDER SCHEDULING A DISCOVERY TELECONFERENCE (#3): A Discovery Teleconference has been set for Monday, March 24, 2014, at 10:00 AM with the Honorable Gregory M. Sleet. Counsel for plaintiff(s) is directed to arrange the conference call. A Joint Agenda letter (see court website) shall be filed no later than the close of business on Thursday, March 20, 2014. The parties shall contact chambers at (302) 573-4559 once all parties are on the line. Ordered by Chief Judge Gregory M. Sleet on 3/13/2014. (ctd)
|
|
Filing 144
SO ORDERED, re #140 Stipulation and Proposed Order of Dismissal of the '627 patent, filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Respiratory LLC, Teva Branded Pharmaceutical Products R&D Inc. Ordered by Chief Judge Gregory M. Sleet on 3/12/2014. (asw)
|
|
SO ORDERED, re #141 MOTION for Pro Hac Vice Appearance of Attorney Paul F. Ware filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Respiratory LLC, Teva Branded Pharmaceutical Products R&D Inc. Ordered by Chief Judge Gregory M. Sleet on 3/*12/2014. (asw)
|
| Filing 143 NOTICE OF SERVICE of (1) Expert Report of Anthony Palmieri III, Ph.D. on Noninfringement of U.S. Patent Nos. 7,105,152 and 7,566,445; (2) Expert Report of Neil Elliot Spingarn Ph.D.; (3) Second Expert Report of Ian L. Scott, D. Phil; (4) Expert Report of Paul Wright, Ph.D.; and (5) Expert Report of David Howlett on Noninfringement of U.S. Patent Nos. 7,105,152 and 7,566,445 filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
| Filing 142 NOTICE OF SERVICE of 1. Rebuttal Expert Report of Adrian E. Smith, 2. Rebuttal Expert Report of James T. Carmichael, 3. Rebuttal Expert Report of Jerry A. Hausman, 4. Rebuttal Expert Report of Paul B. Myrdal, Ph.D., 5. Rebuttal Expert Report of Peter R. Byron, Ph.D., 6. Rebuttal Expert Report of William E. Berger, M.D. filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(Keller, Karen) |
| Filing 141 MOTION for Pro Hac Vice Appearance of Attorney Paul F. Ware - filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (Keller, Karen) |
| Filing 140 STIPULATION [STIPULATION AND PROPOSED ORDER OF DISMISSAL OF U.S. PATENT NO. 6,446,627] by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (O'Byrne, Stephanie) |
| Filing 139 Letter to The Honorable Chief Judge Gregory M. Sleet from Stephanie E. O'Byrne regarding response to letter of earlier today - re #138 Letter. (O'Byrne, Stephanie) |
| Filing 138 Letter to The Honorable Gregory M. Sleet from John C. Phillips, Jr. regarding Defendants' Response to Plaintiffs' Letter of 2/18/14 - re #137 Letter. (Phillips, John) |
| Filing 137 Letter to The Honorable Chief Judge Gregory M. Sleet from Stephanie E. O'Byrne regarding Karen Keller's Letter of February 3, 2014 - re #131 Letter. (O'Byrne, Stephanie) |
| Filing 136 NOTICE OF SERVICE of (1) Opening Expert Report of Stephen G. Kunin; (2) Opening Expert Report of Bernard J. Greenspan, Ph.D.; (3) Expert Report of Ian L. Scott, D. Phil; (4) Expert Report of Warren Finlay, Ph.D.; (5) Expert Report of Richard N. Dalby, Ph.D.; and (6) Expert Report of David Howlett filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
| Filing 135 NOTICE OF SERVICE of (1.) Initial Expert Report of Adrian E. Smith (2.) Initial Expert Report of Steven Dubowsky, Ph.D. (3.) Initial Expert Report of Paul B. Myrdal, Ph.D. (4.) Initial Expert Report of Peter R. Byron, Ph.D. filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(O'Byrne, Stephanie) |
| Filing 134 NOTICE OF SERVICE of (1) Defendants' Second Supplemental Preliminary Invalidity Contentions Regarding U.S. Patent Nos. 6,446,627 and 8,132,712; (2) Defendants' Second Supplemental Preliminary Invalidity Contentions Regarding U.S. Patent Nos. 7,105,152 and 7,566,445; (3) Perrigo Pharmaceuticals Co. and Perrigo Co.'s Second Supplemental Answers and Objections To Plaintiffs' First Set Of Interrogatories; (4) Catalent Pharma Solutions, LLC's Second Supplemental Answers and Objections To Plaintiffs' First Set Of Interrogatories; (5) Perrigo Pharmaceuticals Co. and Perrigo Co.'s Second Supplemental Answers and Objections To Plaintiffs' Second Set Of Interrogatories; (6) Catalent Pharma Solutions, LLC's Second Supplemental Answers and Objections To Plaintiffs' Second Set Of Interrogatories; (7) Perrigo Pharmaceuticals Co.'s and Perrigo Co.'s Supplemental Answers and Objections To Plaintiffs' Third Set Of Interrogatories (Nos. 31-50); and (8) Catalent Pharma Solutions, LLC's Supplemental Answers and Objections To Plaintiffs' Third Set Of Interrogatories filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
| Filing 133 Letter to The Honorable Gregory M. Sleet from John C. Phillips, Jr. regarding Defendants' Response to Plaintiffs' February 3, 2014 Letter - re #131 Letter. (Phillips, John) |
| Filing 132 NOTICE OF SERVICE of Plaintiffs' Second Supplemental Objections and Responses to Defendants' Second Set of Interrogatories (Nos. 26-29, 36) filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(Keller, Karen) |
| Filing 131 Letter to The Honorable Chief Judge Gregory M. Sleet from Karen E. Keller regarding claim construction. (Keller, Karen) |
|
SO ORDERED, re #130 Proposed Order, filed by Perrigo Company, Norton (Waterford) Limited, Catalent Pharma Solutions LLC, Perrigo Pharmaceuticals Co., Norton Healthcare Limited, Teva Respiratory LLC, Teva Branded Pharmaceutical Products R&D Inc. Ordered by Chief Judge Gregory M. Sleet on 1/28/2014. (asw)
|
| Filing 130 Joint PROPOSED ORDER (Stipulation and [proposed] Order Amending Joint Consolidated Schedule) re SO ORDERED, Set Scheduling Order Deadlines,,,,,,,, #69 Letter by Catalent Pharma Solutions LLC, Norton (Waterford) Limited, Norton Healthcare Limited, Perrigo Company, Perrigo Pharmaceuticals Co., Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (Keller, Karen) |
| Filing 129 STIPULATION Regarding Construction of the "Actuator Means" Claim Term by Catalent Pharma Solutions LLC, Norton (Waterford) Limited, Norton Healthcare Limited, Perrigo Company, Perrigo Pharmaceuticals Co., Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (O'Byrne, Stephanie) |
| Filing 128 NOTICE OF SERVICE of 1. Plaintiffs' Responses to Defendants' Second Set of Requests for Admission (Nos. 76-150) 2. Plaintiffs' Objections and Responses to Defendants' Third Set of Rule 33 Interrogatories (Nos. 42-50) 3. Plaintiffs' Supplemental Objections and Responses to Defendants' First Set of Interrogatories (Nos. 7, 10-11, 13-16, 23-25) and 4. Plaintiffs' Supplemental Objections and Responses to Defendants' Second Set of Interrogatories (Nos. 26-32, 36, 38-41) filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(O'Byrne, Stephanie) |
| Filing 127 NOTICE OF SERVICE of (1) Perrigo Pharmaceuticals Co.'s and Perrigo Co.'s Answers and Objections to Plaintiffs' Third Set of Interrogatories (Nos. 31-50); (2) Perrigo Pharmaceuticals Co.'s and Perrigo Co.'s Responses and Objections to Plaintiffs' Second Set of Requests for Admission (Nos. 6-150); (3) Catalent Pharma Solutions, LLC's Answers and Objections to Plaintiffs' Third Set of Interrogatories; (4) Defendants' Supplemental Preliminary Invalidity Contentions; (5) Defendant Catalent Pharma Solutions LLC's Responses and Objections to Plaintiffs' First Set of Requests for Admission (Nos. 1-150); (6) Catalent's Second Supplemental Initial Disclosure; (7) Perrigo's Second Supplemental Initial Disclosure; (8) Perrigo Pharmaceuticals Co. and Perrigo Co.'s Supplemental Answers and Objections to Plaintiffs' Second Set of Interrogatories; (9) Catalent Pharma Solutions, LLC's Supplemental Answers and Objections to Plaintiffs' First Set of Interrogatories; (10) Catalent Pharma Solutions, LLC's Supplemental Answers and Objections to Plaintiffs' Second Set of Interrogatories; (11) Perrigo Pharmaceuticals Co. and Perrigo Co.'s Supplemental Answers and Objections to Plaintiffs' First Set of Interrogatories; and (12) Defendants' Supplemental Preliminary Invalidity Contentions Regarding U.S. Patent Nos. 6,446,627 and 8,132,712 filed by Catalent Pharma Solutions LLC, Perrigo Company.(Haney, Megan) |
| Filing 126 Official Transcript of Markman Hrg. held on 12 12 13 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 1/8/2014. Redacted Transcript Deadline set for 1/21/2014. Release of Transcript Restriction set for 3/18/2014. (kjm) |
| Minute Entry for proceedings held before Judge Gregory M. Sleet - Markman Hearing held on 12/12/2013. Claim Construction Presentations. The court will take this matter under advisement and issue an Order in due course. Discussion on the disputed discovery items as listed in the Joint Agenda submission. (Court Reporter: Kevin Maurer.) (asw) |
| Filing 125 NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Defendants' Second Set of Rule 33 Interrogatories (Nos. 26-41) by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(O'Byrne, Stephanie) |
| Filing 124 NOTICE OF SERVICE of 1) Perrigo Pharmaceuticals Co. and Perrigo Co.'s Answers and Objections to Plaintiffs' Second Set of Interrogatories; and (2) Catalent Pharma Solutions, LLC's Answers and Objections to Plaintiffs' Second Set of Interrogatories by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
| Filing 123 Joint Letter to The Honorable Chief Judge Gregory M. Sleet from Karen E. Keller regarding Discovery Conference. (Keller, Karen) |
| Filing 122 APPENDIX re #120 Claim Construction Answering Brief, [Joint Appendix of Intrinsic Evidence] by Catalent Pharma Solutions LLC, Norton (Waterford) Limited, Norton Healthcare Limited, Perrigo Company, Perrigo Pharmaceuticals Co., Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (Attachments: #1 Exhibit Part 2 of 4, #2 Exhibit Part 3 of 4, #3 Exhibit Part 4 of 4)(Keller, Karen) |
| Filing 121 CLAIM CONSTRUCTION ANSWERING BRIEF re #105 Claim Construction Opening Brief, filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co.. (Attachments: #1 Exhibit A, #2 Exhibit 1 to Dalby Declaration, #3 Exhibit 2 to Dalby Declaration, #4 Exhibit 3 to Dalby Declaration, #5 Exhibit 4 to Dalby Declaration, #6 Exhibit 5 to Dalby Declaration, #7 Exhibit 6 to Dalby Declaration, #8 Exhibit 7 to Dalby Declaration, #9 Exhibit 8 to Dalby Declaration, #10 Exhibit 9 to Dalby Declaration, #11 Exhibit 10 to Dalby Declaration, #12 Exhibit 11 to Dalby Declaration, #13 Exhibit 12 to Dalby Declaration, #14 Exhibit 13 to Dalby Declaration, #15 Exhibit 14 to Dalby Declaration, #16 Exhibit 15 to Dalby Declaration, #17 Exhibit 16 to Dalby Declaration, #18 Exhibit 17 to Dalby Declaration, #19 Exhibit 18 to Dalby Declaration, #20 Exhibit 19 to Dalby Declaration, #21 Exhibit 20 to Dalby Declaration, #22 Exhibit 21 to Dalby Declaration, #23 Exhibit 22 to Dalby Declaration, #24 Exhibit 23 to Dalby Declaration, #25 Exhibit 24 to Dalby Declaration)(Phillips, John) |
| Filing 120 CLAIM CONSTRUCTION ANSWERING BRIEF re #106 Claim Construction Opening Brief filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (Attachments: #1 Exhibits 5-9)(O'Byrne, Stephanie) |
| Filing 119 NOTICE of Subpoena to GlaxoSmithKline by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co. (Attachments: #1 Exhibit 1)(Haney, Megan) |
| Filing 118 NOTICE to Take Deposition of CRAIG DAVIES-CUTTING on December 5, 2013 by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(O'Byrne, Stephanie) |
| Filing 117 NOTICE to Take Deposition of KURT NIELSEN on December 6, 2013 by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(O'Byrne, Stephanie) |
| Filing 116 NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests for Admission to Catalent Pharma Solutions, LLC (Nos. 1-150) (2) Plaintiffs' Second Set of Requests for Admission to Perrigo Pharmaceuticals Co. and Perrigo Co. (Nos. 6-150) (3) Plaintiffs' Third Set of Interrogatories To Catalent Pharma Solutions, LLC (Nos. 31-50) (4) Plaintiffs' Third Set of Interrogatories to Perrigo Pharmaceuticals Co. and Perrigo Co. (Nos. 31-50) by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(Fry, David) |
| Filing 115 NOTICE to Take Deposition of Teva Branded Pharmacuetical Products R&D, Inc., Teva Respiratory, LLC, Norton (Waterford) Limited, and Norton Healthcare Limited on December 13, 2013 (Amended) by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Phillips, John) |
| Filing 114 NOTICE OF SERVICE of (1) Defendants' Second Set of Requests for Admission (Nos. 76-150); and (2) Defendants' Third Set of Rule 33 Interrogatories (Nos. 42-50) by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
| Filing 113 NOTICE to Take Deposition of Steve Viti on December 4, 2013 (Amended) by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
| Filing 112 NOTICE OF SERVICE of (1) Plaintiffs' Responses to Defendants' Notice of Rule 30(b)(6) Deposition to Teva by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(O'Byrne, Stephanie) |
| Filing 111 NOTICE OF SERVICE of Catalent's Responses and Objections to First Notice of Rule 30(b)(6) Deposition by Catalent Pharma Solutions LLC.(Haney, Megan) |
|
ORAL ORDER REGARDING DISCOVERY DISPUTE (#2): The court will address discovery dispute issues on the day of the Markman Hearing (3 hrs.), which is currently set for Thursday, 12/12/2013, at 09:30 AM in Courtroom 4A before Chief Judge Gregory M. Sleet. The parties are directed to file a Joint Agenda Letter (a sample can be located on the court's website) by the close of business on Monday, December 9, 2013. Ordered by Chief Judge Gregory M. Sleet on 11/26/2013. (ctd)
|
| Filing 110 NOTICE to Take Deposition of Julian Blair, Mark Salyer, Fergel Hennessy, Derek Fenlon, Nicholas John Bowman, Michael J. Holroyd, William Richard Trenemanm, Costaninos Panayi on Various Dates in 12/13. by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
|
ORAL ORDER RESCHEDULING THE MARKMAN HEARING: The Markman Hearing (3 hrs.) currently set for Friday, 12/13/2013, at 09:30 AM in Courtroom 4A before Chief Judge Gregory M. Sleet HAS BEEN RESCHEDULED to Thursday, 12/12/2013, at 09:30 AM. Ordered by Chief Judge Gregory M. Sleet on 11/22/2013. (ctd)
|
| Filing 109 NOTICE OF SERVICE of (1) Plaintiffs' Responses to Defendants' Third Set of Requests For Production (Nos. 178-278) by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(O'Byrne, Stephanie) |
| Filing 108 NOTICE OF SERVICE of (1) Perrigo's Responses and Objections to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 70-124); and (2) Catalent's Responses and Objections to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 68-120) by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
| Filing 107 NOTICE to Take Deposition of Mushtaq Fruitwala on November 20, 2013 by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(Fry, David) |
| CORRECTING ENTRY: The main document in D.I. #105 CLAIM CONSTRUCTION OPENING BRIEF has been replaced with its corrected version. (asw) |
| Filing 106 CLAIM CONSTRUCTION OPENING BRIEF filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(Phillips, John) |
| Filing 105 CLAIM CONSTRUCTION OPENING BRIEF filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (O'Byrne, Stephanie) (Main Document 105 replaced on 11/18/2013) (asw). |
| Filing 104 NOTICE of Subpoena to 3M Company by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co. (Haney, Megan) |
| Pro Hac Vice Attorney Timothy J. Rousseau for Teva Branded Pharmaceutical Products R&D Inc. added for electronic noticing. (els) |
| Filing 103 NOTICE of Subpoena to Robert A. Moris by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co. (Haney, Megan) |
| Filing 102 NOTICE of Subpoena to David W. Schultz by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co. (Haney, Megan) |
| Filing 101 NOTICE of Subpoena to Robert K. Schultz by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co. (Haney, Megan) |
| Filing 100 NOTICE of Subpoena to Ted K. Ringsred by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co. (Haney, Megan) |
| Filing 99 NOTICE of Subpoena to Mary Susan Howard by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co. (Haney, Megan) |
|
SO ORDERED, re #98 MOTION for Pro Hac Vice Appearance of Attorney Timothy J. Rousseau filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Respiratory LLC, Teva Branded Pharmaceutical Products R&D Inc. Ordered by Chief Judge Gregory M. Sleet on 11/12/2013. (asw)
|
| Filing 98 MOTION for Pro Hac Vice Appearance of Attorney Timothy J. Rousseau - filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (O'Byrne, Stephanie) |
| Filing 97 AMENDED DOCUMENT by Catalent Pharma Solutions LLC, Norton (Waterford) Limited, Norton Healthcare Limited, Perrigo Company, Perrigo Pharmaceuticals Co., Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. Amendment to #92 Claim Construction Chart, Amended Joint Claim Construction Chart. (Attachments: #1 Exhibits A-D)(Phillips, John) |
| Filing 96 NOTICE OF SERVICE of Plaintiffs' Second Set of Interrogatories to Perrigo Pharmaceuticals Co. and Perrigo Co. (Nos. 18-30) and Plaintiffs' Second Set of Interrogatories to Catalent Pharma Solutions, LLC (Nos. 18-30) by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(O'Byrne, Stephanie) |
| Filing 95 NOTICE to Take Deposition of Derek Fenlon, Nicholas John Bowman, Michael John Holroyd, Costaninos Panayi, William Richard Treneman, and Julian Blair on December 3, 2013, December 6, 2013, December 9, 2013, December 16, 2013, December 18, 2013, and December 20, 2013, respectively by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
| Filing 94 NOTICE OF SERVICE of Defendants' Second Set of Rule 33 Interrogatories (Nos. 26-41) by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
| Filing 93 NOTICE of Subpoena Directed to Bespak Europe Limited by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC (O'Byrne, Stephanie) |
| Filing 92 CLAIM Construction Chart by Catalent Pharma Solutions LLC, Norton (Waterford) Limited, Norton Healthcare Limited, Perrigo Company, Perrigo Pharmaceuticals Co., Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (Attachments: #1 Exhibits A through D)(O'Byrne, Stephanie) |
|
Filing 91
SO ORDERED, re #87 MOTION (UNOPPOSED) for the Issuance of a Letter Request for International Judicial Assistance Pursuant to the Hague Convention on the Taking of Evidence Aboard filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Respiratory LLC, Teva Branded Pharmaceutical Products R&D Inc. Signed by Chief Judge Gregory M. Sleet on 10/31/2013. (asw)
|
| Filing 90 NOTICE of Subpoena to 3M Company to Testify at a Deposition in a Civil Action by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co. (Haney, Megan) |
| Filing 89 NOTICE OF SERVICE of NOTICE OF DEPOSITION OF JAMES BOOYDEGRAAFF and NOTICE OF DEPOSITION OF ELIZABETH BICKLER by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(O'Byrne, Stephanie) |
| Filing 88 Letter to The Honorable Chief Judge Gregory M. Sleet from Stephanie E. O'Byrne regarding Enclosing two execution copies of the Letter Request for International Judicial Assistance Pursuant to the Hague Convention on the Taking of Evidence Abroad in Civil or Commercial Matters to the Appropriate Judicial Authority in the United Kingdom - re #87 MOTION (UNOPPOSED) for the Issuance of a Letter Request for International Judicial Assistance Pursuant to the Hague Convention on the Taking of Evidence Aboard . (O'Byrne, Stephanie) |
| Filing 87 MOTION (UNOPPOSED) for the Issuance of a Letter Request for International Judicial Assistance Pursuant to the Hague Convention on the Taking of Evidence Aboard - filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (Attachments: #1 Letter of Request for International Judicial Assistance Pursuant to the Hague Convention on the Taking of Evidence Abroad in Civil or Commercial Matters to the Appropriate Judicial Authority in the United Kingdom)(O'Byrne, Stephanie) |
| Filing 86 NOTICE of Subpoena to Virginia Commonwealth University by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co. (Attachments: #1 Exhibit 1)(Haney, Megan) |
| Filing 85 NOTICE of Subpoena to Peter R. Byron, Ph.D. by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co. (Attachments: #1 Exhibit 1)(Phillips, John) |
| Filing 84 NOTICE to Take Deposition of Teva Branded Pharmaceutical Products R&D, Inc. and Teva Respiratory, LLC pursuant to Pursuant to Fed. R. Civ. P. 30(b)(6) on a mutually agreeable date by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Phillips, John) |
| Filing 83 NOTICE OF SERVICE of Perrigo's Responses and Objections to First Notice of Rule 30(b)(6) Deposition by Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
| Filing 82 NOTICE OF SERVICE of Defendants' Third Requests for Production (Nos. 178-278) by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
| Filing 81 NOTICE OF SERVICE of (1) Plaintiffs' Second Set of Requests for The Production of Documents and Things To Catalent Pharma Solutions, LLC (Nos. 68-120) (2) Plaintiffs' Second Set of Requests for The Production of Documents and Things to Perrigo Pharmaceuticals Co. and Perrigo Co. (Nos. 70-124) by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(Fry, David) |
| Filing 80 NOTICE to Take Deposition of Steve Viti on November 15, 2013 by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
| Filing 79 NOTICE OF SERVICE of Defendants' Preliminary Invalidity Contentions Regarding U.S. Patent Nos. 6,446,627 and 8,132,712 by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
| Filing 78 NOTICE OF SERVICE of (1) Plaintiffs' Supplemental Disclosure of Preliminary Infringement Contentions for U.S. Patent Nos. 6,446,627 and 8,132,712 by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(Fry, David) |
| Filing 77 NOTICE OF SERVICE of (1) Plaintiffs' Responses to Defendants' First Set of Requests for Admission (Nos. 1-75) (2) Plaintiffs' Objections and Responses to Defendants' First Set of Rule 33 Interrogatories (Nos. 1-25) by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(Fry, David) |
| Filing 76 REPLY BRIEF re #61 MOTION for Leave to File Defendants' Motion to Supplement Their Counterclaims in the Lead Action filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co.. (Attachments: #1 Exhibit C)(Phillips, John) |
| Filing 75 REDACTED VERSION of #74 Response to Motion, (Public Version) by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (O'Byrne, Stephanie) |
| Filing 74 [SEALED] RESPONSE to Motion re #61 MOTION for Leave to File Defendants' Motion to Supplement Their Counterclaims in the Lead Action filed by Norton (Waterford) Limited, Norton Healthcare Limited, Perrigo Pharmaceuticals Co., Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C)(O'Byrne, Stephanie) |
| Filing 73 Official Transcript of T/C held on 09 12 13 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 10/21/2013. Redacted Transcript Deadline set for 10/31/2013. Release of Transcript Restriction set for 12/30/2013. (kjm) |
| Filing 72 NOTICE OF SERVICE of (1) Perrigo's Supplemental Initial Disclosure; (2) Catalent's Supplemental Initial Disclosure; (3) Perrigo's Supplemental Paragraph 3 Initial Disclosures; and (4) Catalent's Supplemental Paragraph 3 Initial Disclosures by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
| Filing 71 NOTICE OF SERVICE of (1) Plaintiffs' Supplemental Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard For Discovery (2) Plaintiffs' Supplemental Initial Disclosures by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(O'Byrne, Stephanie) |
| Filing 70 NOTICE OF SERVICE of Perrigo Pharmaceuticals Co.'s and Perrigo Co.'s Responses and Objections to Plaintiffs' First Set of Requests for Admission (Nos. 1-5) by Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
|
SO ORDERED, re #69 Letter regarding proposed AMENDED SCHEDULING ORDER, ORDER, Setting Scheduling Order Deadlines ( Final Joint Claim Chart due by 11/1/2013., Claim Construction Opening Brief due by 11/15/2013., Claim Construction Answering Brief due by 12/6/2013., A Pretrial Conference (by telephone) is set for 6/9/2014 at 03:30 PM before Judge Gregory M. Sleet., Amended Pleadings due by 11/8/2013., Fact Discovery due by 1/3/2014., Expert Reports: Opening due by 1/31/2014, Rebuttal due by 2/28/2014, Reply due by 3/14/2014, Completion of Expert Discovery due by 4/14/2014., Initial Disclosures due by 9/27/2013 - DO NOT FILE INITIAL DISCLOSURES WITH THE COURT., Joinder of Parties due by 11/8/2013., A Markman Hearing (3 hrs) is set for 12/13/2013 at 09:30 AM in Courtroom 4A before Judge Gregory M. Sleet., Proposed Pretrial Order due by 5/21/2014., A 6-day Bench Trial is set for 6/25/2014 at 09:00 AM in Courtroom 4A before Judge Gregory M. Sleet.). Ordered by Chief Judge Gregory M. Sleet on 9/25/2013. (asw)
|
| Filing 69 Letter to The Honorable Gregory M. Sleet from John W. Shaw regarding Proposed Scheduling Order. (Shaw, John) |
| Filing 68 Amended STATUS REPORT [Amended Joint Status Report] by Catalent Pharma Solutions LLC, Norton (Waterford) Limited, Norton Healthcare Limited, Perrigo Company, Perrigo Pharmaceuticals Co., Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (Shaw, John) |
| Filing 67 REDACTED VERSION of #52 Answering Brief in Opposition, by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (O'Byrne, Stephanie) |
| Filing 66 NOTICE OF SERVICE of (1) Notice of Deposition of Craig Davies-Cutting (2) Notice of Deposition of Elizabeth Bickler (3) Notice of Deposition of Mushtaq Fruitwala (4) Notice of Deposition of David Wilcox (5) Notice of Deposition of James Booydegraaff (6) Notice of Deposition of Kurt Nielsen (7) Notice of Deposition of Brian Schuster (8) Plaintiffs' First Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) to Perrigo Pharmaceuticals Co. and Perrigo Co. (9) Plaintiffs' First Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) to Catalent Pharma Solutions, LLC by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(Fry, David) |
| Filing 65 NOTICE of Withdrawal Of Discovery by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC re #55 Notice of Service, (Fry, David) |
|
Filing 64
SO ORDERED, re #62 Stipulation filed by Perrigo Company, Catalent Pharma Solutions LLC, Perrigo Pharmaceuticals Co. Signed by Chief Judge Gregory M. Sleet on 9/17/2013. (asw)
|
| Filing 63 ANSWER to #9 Answer to Complaint, Counterclaim,, by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(O'Byrne, Stephanie) |
| Filing 62 STIPULATION to Suspend Submission of Opening Claim Construction Briefs by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co.. (Phillips, John) |
| Filing 61 MOTION for Leave to File Defendants' Motion to Supplement Their Counterclaims in the Lead Action - filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co.. (Attachments: #1 Text of Proposed Order, #2 Exhibit A, #3 Exhibit B)(Phillips, John) |
| Filing 60 NOTICE to Take Deposition of Robert K. Schultz, David W. Schultz, and Robert A. Moris on October 23, 2013; October 25, 2013; and October 30, 2013, respectively by Catalent Pharma Solutions LLC, Perrigo Company.(Phillips, John) |
|
Filing 59
SO ORDERED, re #58 Letter and Corrected (Proposed) Order Granting Defendants' Motion to Consolidate C.A. 13-1441 GMS. Signed by Chief Judge Gregory M. Sleet on 9/13/2013. (asw)
|
| Filing 58 Letter to The Honorable Gregory M. Sleet from John C. Phillips, Jr. regarding Corrected Version of Proposed Order to Defendants' Motion to Consolidate - re #56 Order on Motion to Consolidate Cases,. (Attachments: #1 Text of Proposed Order)(Phillips, John) |
|
Filing 57
SO ORDERED, re #54 MOTION for Pro Hac Vice Appearance of Attorney Daniel B. Reagan filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Respiratory LLC, Teva Branded Pharmaceutical Products R&D Inc. Ordered by Chief Judge Gregory M. Sleet on 9/12/2013. (asw)
|
|
Filing 56
[SEALED] ORDER granting #45 Motion to Consolidate Cases. This case is CONSOLIDATED with C.A. No. 13-1441 GMS. C.A. 12-1101 GMS shall be the LEAD case and all papers shall be filed only in C.A. 12-1101 GMS. Signed by Chief Judge Gregory M. Sleet on 9/12/2013. (asw)
|
| Minute Entry for proceedings held before Judge Gregory M. Sleet - Telephone Conference held on 9/12/2013. Discussion on the filing of D.I. #45 and the proposed scheduling order. The parties shall follow the court's directives as discussed. The court will RESCHEDULE this matter accordingly. (Court Reporter: Kevin Maurer.) (asw) |
| Filing 55 NOTICE OF SERVICE of (1) Plaintiffs' Second Set of Requests For Admission To Perrigo Pharmaceuticals Co. And Perrigo Co. (Nos. 6-215) by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(O'Byrne, Stephanie) |
| Filing 54 MOTION for Pro Hac Vice Appearance of Attorney Daniel B. Reagan - filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (O'Byrne, Stephanie) |
| Filing 53 Letter to The Honorable Gregory M. Sleet from John W. Shaw regarding Request for Oral Argument on Defendants' Motion to Consolidate - re #45 MOTION to Consolidate Cases with C.A. No. 13-1441-GMS. (Shaw, John) |
| Filing 52 [SEALED] ANSWERING BRIEF in Opposition re #45 MOTION to Consolidate Cases with C.A. No. 13-1441-GMS filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.Reply Brief due date per Local Rules is 9/23/2013. (Attachments: #1 Certificate of Service, #2 Exhibit A)(O'Byrne, Stephanie) |
| Filing 51 Letter to The Honorable Gregory M. Sleet from John C. Phillips, Jr. regarding Discovery Teleconference scheduled for Thursday, September 12 at 9:30 a.m. - re Oral Order,,. (Phillips, John) |
| Filing 50 NOTICE OF SERVICE of (1) Defendants' First Set of Interrogatories (Nos. 1-25); and (2) Defendants' First Set of Requests for Admission (Nos. 1-75) by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Phillips, John) |
| Filing 49 CLAIM Construction Chart by Catalent Pharma Solutions LLC, Norton (Waterford) Limited, Norton Healthcare Limited, Perrigo Company, Perrigo Pharmaceuticals Co., Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (O'Byrne, Stephanie) |
| Filing 48 REDACTED VERSION of #46 Declaration, by Perrigo Company, Perrigo Pharmaceuticals Co.. (Phillips, John) |
| Filing 47 REDACTED VERSION of #45 MOTION to Consolidate Cases with C.A. No. 13-1441-GMS by Perrigo Company, Perrigo Pharmaceuticals Co.. (Phillips, John) |
|
ORAL ORDER SCHEDULING A DISCOVERY TELECONFERENCE (#1): A Discovery Teleconference has been set for Thursday, September 12, 2013, at 9:30 AM with the Honorable Gregory M. Sleet. Counsel for plaintiff(s) is directed to arrange the conference call. A Joint Agenda letter (see court website) shall be filed no later than the close of business on Monday, September 9, 2013. The parties shall contact chambers at (302) 573-4559 once all parties are on the line. Ordered by Chief Judge Gregory M. Sleet on 8/29/2013. (ctd)
|
| Filing 46 [SEALED] DECLARATION re #45 MOTION to Consolidate Cases with C.A. No. 13-1441-GMS Declaration of William F. Ward in Support of Defendants' Motion to Consolidate C.A. No. 13-1441-GMS by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D (part 1), #5 Exhibit D (part 2), #6 Exhibit D (part 3), #7 Exhibit D (part 4), #8 Exhibit E)(Phillips, John) |
| Filing 45 [SEALED] MOTION to Consolidate Cases with C.A. No. 13-1441-GMS - filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co.. (Attachments: #1 Text of Proposed Order)(Phillips, John) |
| Filing 44 NOTICE of Subpoena to 3M Company by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co. (Haney, Megan) |
| Filing 43 NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Admission to Perrigo Pharmaceuticals Co. and Perrigo Co. (Nos. 1-5) by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(Fry, David) |
| Filing 42 NOTICE of Subpoena to 3M Company by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co. (Haney, Megan) |
| Pro Hac Vice Attorney Neil B. McLaughlin for Perrigo Pharmaceuticals Co. added for electronic noticing. (dmp, ) |
| Pro Hac Vice Attorney Nicole E. Kopinski for Perrigo Pharmaceuticals Co. added for electronic noticing. (dmp, ) |
| Filing 41 NOTICE OF SERVICE of (1) Perrigo Pharmaceuticals Co. and Perrigo Co.'s Answers and Objections to Plaintiffs' First Set of Interrogatories; and (2) Catalent Pharma Solutions, LLC's Answers and Objections to Plaintiffs' First Set of Interrogatories by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
| Filing 40 MOTION for Pro Hac Vice Appearance of Attorney Neil B. McLaughlin and Nicole E. Kopinski - filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co.. (Attachments: #1 McLaughlin Pro Hac Certification, #2 Kopinski Pro Hac Certification)(Haney, Megan) |
|
SO ORDERED, re #40 MOTION for Pro Hac Vice Appearance of Attorney Neil B. McLaughlin and Nicole E. Kopinski filed by Perrigo Company, Catalent Pharma Solutions LLC, Perrigo Pharmaceuticals Co. Ordered by Chief Judge Gregory M. Sleet on 8/5/2013. (asw)
|
| Filing 39 NOTICE OF SERVICE of (1) Plaintiffs' Responses To Defendants' Second Requests For Production (Nos. 4-177) by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(O'Byrne, Stephanie) |
|
SO ORDERED, re #38 STIPULATION TO EXTEND TIME Time for Plaintiffs and Defendants to substantially complete document production to August 16, 2013 filed by Perrigo Company, Catalent Pharma Solutions LLC, Perrigo Pharmaceuticals Co. Ordered by Chief Judge Gregory M. Sleet on 7/30/2013. (asw)
|
| Filing 38 STIPULATION TO EXTEND TIME Time for Plaintiffs and Defendants to substantially complete document production to August 16, 2013 - filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co.. (Phillips, John) |
| Filing 37 NOTICE OF SERVICE of 1. Plaintiffs' First Set of Interrogatories to Catalent Pharma Solutions, LLC (Nos. 1-17) and 2. Plaintiffs' First Set of Interrogatories to Perrigo Pharmaceuticals Co. and Perrigo Co. (Nos. 1-17) by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(O'Byrne, Stephanie) |
| Filing 36 NOTICE OF SERVICE of Defendants' Second Requests for Production (Nos. 4-177) by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
| Filing 35 NOTICE OF SERVICE of (1) Perrigo's Responses and Objections to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-69); and (2) Catalent's Response to Plaintiffs' First Set of Requests for the Production of Documents and Things to Catalent Pharma Solutions, LLC (Nos. 1-67) by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
| Filing 34 NOTICE OF SERVICE of Defendants' Preliminary Invalidity Contentions by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
| Filing 33 NOTICE requesting Clerk to remove Timothy F. Peterson as co-counsel. Reason for request: No longer with Rakoczy Molino Mazzochi Siwik LLP. (Haney, Megan) |
| Filing 32 NOTICE OF SERVICE of 1. Plaintiffs' First Set of Requests for the Production of Documents and Things to Catalent Pharma Solutions, LLC (Nos. 1-67) 2. Plaintiffs' First Set of Requests for the Production of Documents and Things to Perrigo Pharmaceuticals Co. and Perrigo Co. (Nos. 1-69) by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(O'Byrne, Stephanie) |
| Filing 31 NOTICE OF SERVICE of Plaintiffs' Disclosures of Preliminary Infringement Contentions by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(Shaw, John) |
| Filing 30 NOTICE OF SERVICE of (1) Plaintiffs' Responses to Defendants' First Set of Requests for the Production of Documents And Things (Nos. 1-3) by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(O'Byrne, Stephanie) |
|
Filing 29
SO ORDERED, re #28 Proposed Order, filed by Perrigo Company, Norton (Waterford) Limited, Catalent Pharma Solutions LLC, Perrigo Pharmaceuticals Co., Norton Healthcare Limited, Teva Respiratory LLC, Teva Branded Pharmaceutical Products R&D Inc. Signed by Chief Judge Gregory M. Sleet on 4/9/2013. (asw)
|
| Filing 28 Joint PROPOSED ORDER Regarding E-Discovery And Production of Electronically Stored Information (Stipulated Proposed Order by Catalent Pharma Solutions LLC, Norton (Waterford) Limited, Norton Healthcare Limited, Perrigo Company, Perrigo Pharmaceuticals Co., Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (Shaw, John) |
| Pro Hac Vice Attorney Timothy F. Peterson for Perrigo Pharmaceuticals Co. added for electronic noticing. (dmp, ) |
|
SO ORDERED, re #27 Proposed Order, filed by Perrigo Company, Norton (Waterford) Limited, Catalent Pharma Solutions LLC, Perrigo Pharmaceuticals Co., Norton Healthcare Limited, Teva Respiratory LLC, Teva Branded Pharmaceutical Products R&D Inc. Ordered by Chief Judge Gregory M. Sleet on 3/25/2013. (asw)
|
| Filing 27 PROPOSED ORDER (Stipulated Protective Order) by Catalent Pharma Solutions LLC, Norton (Waterford) Limited, Norton Healthcare Limited, Perrigo Company, Perrigo Pharmaceuticals Co., Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (Attachments: #1 Exhibit A)(O'Byrne, Stephanie) |
| Filing 26 NOTICE OF SERVICE of (1) Plaintiffs' Disclosures Pursuant to Paragraph 3 Of The Delaware Default Standard For Discovery by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(O'Byrne, Stephanie) |
| Filing 25 NOTICE OF SERVICE of (1) Catalent's Paragraph 3 Initial Disclosures and (2) Perrigo's Paragraph 3 Initial Disclosures by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Phillips, John) |
| Filing 24 NOTICE OF SERVICE of (1) Plaintiffs' Disclosure To Defendants Pursuant To Section 4.A. Of The Default Standard For Discovery by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(O'Byrne, Stephanie) |
| Filing 23 MOTION for Pro Hac Vice Appearance of Attorney Andrew E. Riley - filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (O'Byrne, Stephanie) |
| Pro Hac Vice Attorney Andrew Riley for Teva Branded Pharmaceutical Products R&D Inc. added for electronic noticing. (dmp, ) |
|
SO ORDERED, re #23 MOTION for Pro Hac Vice Appearance of Attorney Andrew E. Riley filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Respiratory LLC, Teva Branded Pharmaceutical Products R&D Inc. Ordered by Chief Judge Gregory M. Sleet on 3/21/2013. (asw)
|
|
SO ORDERED, re #22 Joint STIPULATION TO EXTEND TIME (and proposed order) to file a joint proposed protective order to March 22, 2013 filed by Perrigo Company, Norton (Waterford) Limited, Catalent Pharma Solutions LLC, Perrigo Pharmaceuticals Co., Norton Healthcare Limited, Teva Respiratory LLC, Teva Branded Pharmaceutical Products R&D Inc. Ordered by Chief Judge Gregory M. Sleet on 3/19/2013. (asw)
|
| Filing 22 Joint STIPULATION TO EXTEND TIME (and proposed order) to file a joint proposed protective order to March 22, 2013 - filed by Catalent Pharma Solutions LLC, Norton (Waterford) Limited, Norton Healthcare Limited, Perrigo Company, Perrigo Pharmaceuticals Co., Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (O'Byrne, Stephanie) |
| Filing 21 NOTICE OF SERVICE of Defendants' First Set of Requests for Production (Nos. 1-3) by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co..(Haney, Megan) |
| CORRECTING ENTRY: The docket text in the 'SO ORDERED' (re: Proposed Scheduling Order) entered on 3/4/2013 has been corrected to exclude the referral to the Magistrate Judge for ADR. A referral to the Magistrate Judge was not requested by the parties. (asw) |
| Filing 20 NOTICE OF SERVICE of (1) Catalent's Initial Disclosure; and (2) Perrigo's Initial Disclosure by Catalent Pharma Solutions LLC, Perrigo Company.(Haney, Megan) |
| Filing 19 NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(Shaw, John) |
| CORRECTING ENTRY: Due to the court's typographical error, the docket text (regarding the date for the Pretrial Conference and the Reply deadline for Expert Reports) has been corrected. (asw) |
|
SO ORDERED, re #17 Proposed Order, filed by Perrigo Company, Norton (Waterford) Limited, Catalent Pharma Solutions LLC, Perrigo Pharmaceuticals Co., Norton Healthcare Limited, Teva Respiratory LLC, Teva Branded Pharmaceutical Products R&D Inc., ORDER, Setting Scheduling Order Deadlines: ( Claim Construction Opening Brief due by 9/20/2013., Claim Construction Answering Brief due by 10/14/2013., A Pretrial Conference is set for 5/28/2014 at 10:00 AM in Courtroom 4A before Judge Gregory M. Sleet., Amended Pleadings due by 9/13/2013., Fact Discovery due by 10/11/2013., Expert Reports: Opening due by 12/24/2013., Rebuttal due by 1/24/2014., Reply due by 2/14/2014., Completion of Expert Discovery due by 3/21/2014., Joinder of Parties due by 6/26/2013., A Markman Hearing (3 hrs) is set for 11/26/2013 at 09:30 AM in Courtroom 4A before Judge Gregory M. Sleet., Proposed Pretrial Order due by 4/21/2014., A 6-day Bench Trial is set for 6/25/2014 at 09:00 AM in Courtroom 4A before Judge Gregory M. Sleet.). Ordered by Chief Judge Gregory M. Sleet on 3/4/2013. (asw)
|
| Filing 18 MOTION for Pro Hac Vice Appearance of Attorney Timothy F. Peterson - filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co.. (Attachments: #1 Peterson Pro Hac Certification)(Haney, Megan) |
|
SO ORDERED, re #18 MOTION for Pro Hac Vice Appearance of Attorney Timothy F. Peterson filed by Perrigo Company, Catalent Pharma Solutions LLC, Perrigo Pharmaceuticals Co. Ordered by Chief Judge Gregory M. Sleet on 2/28/2013. (asw)
|
| Filing 17 PROPOSED ORDER [Proposed Scheduling Order] re #16 Transcript,, by Catalent Pharma Solutions LLC, Norton (Waterford) Limited, Norton Healthcare Limited, Perrigo Company, Perrigo Pharmaceuticals Co., Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (Attachments: #1 Cover Letter to The Honorable Gregory M. Sleet)(O'Byrne, Stephanie) |
| Filing 16 Official Transcript of Scheduling teleconference held on 2/19/13 before Judge Sleet. Court Reporter/Transcriber Renee A. Ewing,Telephone number 302-593-6563. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 3/15/2013. Redacted Transcript Deadline set for 3/25/2013. Release of Transcript Restriction set for 5/23/2013. (kjm) |
| Minute Entry for proceedings held before Judge Gregory M. Sleet - Telephone Scheduling Conference held on 2/19/2013. Initial Disclosures due by 3/5/2013., Amendment of Pleading/Joinder of Parties due by 6/26/2013., Fact Discovery due by 10/11/2013., Expert Reports: Opening due by 12/24/2013, Answering due by 1/24/2014, Reply due by 2/14/2014, Completion of Expert Discovery due by 3/21/2014., Claim Construction Briefing: Final Joint Claim Chart due by 9/6/2013., Opening due by 9/20/2013., Answering due by 10/14/2013., Markman Hearing (3 hrs) set for 11/26/2013 at 9:30 AM., Pretrial Order due by 4/21/2014., Pretrial Conference (by phone) set for 5/28/2014 at 10:00 AM., 6-day Bench Trial set for 6/25/2014 at 9:00 AM. Plaintiff's counsel shall file a proposed scheduling order with the court by 2/27/2013. (Court Reporter: Renee Ewing for Kevin Maurer.) (asw) |
| Filing 15 Joint STATUS REPORT by Catalent Pharma Solutions LLC, Norton (Waterford) Limited, Norton Healthcare Limited, Perrigo Company, Perrigo Pharmaceuticals Co., Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (Attachments: #1 Exhibit A-B)(Shaw, John) |
| Pro Hac Vice Attorney Brian J. Prew for Teva Branded Pharmaceutical Products R&D Inc. added for electronic noticing. (dmp, ) |
| Filing 14 MOTION for Pro Hac Vice Appearance of Attorney Brian J. Prew - filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (Shaw, John) |
|
SO ORDERED, re #14 MOTION for Pro Hac Vice Appearance of Attorney Brian J. Prew filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Respiratory LLC, Teva Branded Pharmaceutical Products R&D Inc. Ordered by Chief Judge Gregory M. Sleet on 2/5/2013. (asw)
|
|
ORAL ORDER SCHEDULING A RULE 16.2b SCHEDULING TELECONFERENCE: A Rule 16.2b Scheduling Teleconference has been set in this matter for Tuesday, February 19, 2013, at 2:00 PM with the Honorable Gregory M. Sleet. A Joint Status Report (see court's website for sample) shall be filed no later than the close of business on Thursday, February 14, 2013. Counsel for plaintiff is directed to initiate the conference call and contact chambers at (302) 573-6470 once all parties are on the line. Ordered by Chief Judge Sleet on 2/5/2013.(ctd)
|
| Filing 13 NOTICE requesting Clerk to remove Kevin J. DeJong as co-counsel. Reason for request: No longer on the case. (Shaw, John) |
| Pro Hac Vice Attorney Brian P. Murray,William F. Ward for Perrigo Company added for electronic noticing. (rbe) |
| Pro Hac Vice Attorney Yixin H. Tang,Matthew T. Lord,William A. Rakoczy for Perrigo Pharmaceuticals Co. added for electronic noticing. (dmp, ) |
| Pro Hac Vice Attorney Joseph T. Jaros for Perrigo Pharmaceuticals Co. added for electronic noticing. (dmp, ) |
| Filing 12 ANSWER to #9 Answer to Complaint, Counterclaim,, (Plaintiffs' Answer To Perrigo Pharmaceutical Co.'s Counterclaims) by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC.(Shaw, John) |
|
SO ORDERED, re #11 MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Joseph T. Jaros, Matthew T. Lord, William F. Ward, Yixin H. Tang and Brian P. Murray filed by Perrigo Company, Catalent Pharma Solutions LLC, Perrigo Pharmaceuticals Co. Ordered by Chief Judge Gregory M. Sleet on 11/29/2012. (asw)
|
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Joseph T. Jaros, Matthew T. Lord, William F. Ward, Yixin H. Tang and Brian P. Murray - filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co.. (Attachments: #1 Rakoczy Pro Hac Certification, #2 Jaros Pro Hac Certification, #3 Lord Pro Hac Certification, #4 Ward Pro Hac Certification, #5 Tang Pro Hac Certification, #6 Murray Pro Hac Certification)(Haney, Megan) |
| Filing 10 Disclosure Statement pursuant to Rule 7.1 filed by Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co. identifying Corporate Parent Perrigo Co. for Perrigo Pharmaceuticals Co.; Corporate Parent Catalent Pharma Solutions, Inc. for Catalent Pharma Solutions LLC.. (Phillips, John) |
| Filing 9 ANSWER to #1 Complaint, with Jury Demand , COUNTERCLAIM against Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC by Perrigo Pharmaceuticals Co., Perrigo Company, Catalent Pharma Solutions LLC. (Attachments: #1 Exhibit A, #2 Exhibit B)(Phillips, John) |
| CORRECTING ENTRY: The docket text in D.I. #6 Motion for Pro Hac Vice has been corrected to include Attorney Ira Levy. (asw) |
| Pro Hac Vice Attorney Ira J. Levy,Kevin J. DeJong,Nicholas K. Mitrokostas,Dary L. Wiesen,David M. Hashmall for Teva Branded Pharmaceutical Products R&D Inc. added for electronic noticing. (rbe) |
|
SO ORDERED, re #6 MOTION for Pro Hac Vice Appearance of Attorney David M. Hashmall, Daryl L. Wiesen, Nicholas K. Mitrokostas, and Kevin J. DeJong filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Respiratory LLC, Teva Branded Pharmaceutical Products R&D Inc. Ordered by Chief Judge Gregory M. Sleet on 9/12/11. (mmm)
|
| Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. (rjb) |
| Filing 8 WAIVER OF SERVICE returned executed by Teva Respiratory LLC, Teva Branded Pharmaceutical Products R&D Inc., Norton (Waterford) Limited, Norton Healthcare Limited: For Perrigo Company waiver sent on 9/5/2012, answer due 11/5/2012; Perrigo Pharmaceuticals Co. waiver sent on 9/5/2012, answer due 11/5/2012. (Shaw, John) |
| Filing 7 WAIVER OF SERVICE returned executed by Teva Respiratory LLC, Teva Branded Pharmaceutical Products R&D Inc., Norton (Waterford) Limited, Norton Healthcare Limited: For Catalent Pharma Solutions LLC waiver sent on 9/5/2012, answer due 11/5/2012. (Shaw, John) |
| Summons Issued with Magistrate Consent Notice attached as to Catalent Pharma Solutions LLC on 9/6/2012; Perrigo Company (c/o DE Secretary of State and c/o CSC-Lawyers Incorporating Service) on 9/6/2012; Perrigo Pharmaceuticals Co. (c/o DE Secretary of State and c/o CSC-Lawyers Incorporating Service) on 9/6/2012. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (dzb, ) |
| Filing 6 MOTION for Pro Hac Vice Appearance of Attorney David M. Hashmall, Daryl L. Wiesen, Nicholas K. Mitrokostas, Ira Levy and Kevin J. DeJong - filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (dzb ) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1 filed by Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC identifying Corporate Parent Teva Pharmaceutical Industries Limited for Norton (Waterford) Limited, Norton Healthcare Limited, Teva Branded Pharmaceutical Products R&D Inc., Teva Respiratory LLC. (dzb, ) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,105,152; 7,566,445;. (dzb, ) Modified on 9/6/2012 (dzb, ). |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than 7/25/12. Date of Expiration of Patent: '152 - 9/12/23; '445 - 6/4/17.Thirty Month Stay Deadline: 1/25/2015. (dzb, ) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (dzb, ) |
| Filing 1 COMPLAINT filed with Jury Demand against Catalent Pharma Solutions LLC, Perrigo Company, Perrigo Pharmaceuticals Co. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-1133533.) - filed by Teva Respiratory LLC, Teva Branded Pharmaceutical Products R&D Inc., Norton (Waterford) Limited, Norton Healthcare Limited. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Civil Cover Sheet)(dzb, ) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
